BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 34942323)

  • 1. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
    Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
    J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pteryxin attenuates LPS-induced inflammatory responses and inhibits NLRP3 inflammasome activation in RAW264.7 cells.
    Zhen D; Xuan TQ; Hu B; Bai X; Fu DN; Wang Y; Wu Y; Yang J; Ma Q
    J Ethnopharmacol; 2022 Feb; 284():114753. PubMed ID: 34662667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anti-inflammatory effects of peimine, peiminine, and forsythoside a combination on LPS-induced acute lung injury by inhibition of the IL-17-NF-κB/MAPK pathway activation.
    Liu C; Zhen D; Du H; Gong G; Wu Y; Ma Q; Quan ZS
    J Ethnopharmacol; 2022 Sep; 295():115343. PubMed ID: 35533916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.
    Zhen D; Liu C; Huang T; Fu D; Bai X; Ma Q; Jiang M; Gong G
    J Ethnopharmacol; 2022 Oct; 296():115497. PubMed ID: 35738472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
    Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
    J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo.
    Wang J; Ren C; Bi W; Batu W
    J Ethnopharmacol; 2023 Mar; 303():115948. PubMed ID: 36423713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
    Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
    Front Immunol; 2022; 13():846384. PubMed ID: 35281058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
    Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
    Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
    J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
    Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
    J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
    Yang H; Lv H; Li H; Ci X; Peng L
    Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
    Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
    Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation.
    Qin W; Tong X; Liang R; Tang K; Wu X; Jia Y; Tan N
    J Ethnopharmacol; 2021 May; 271():113827. PubMed ID: 33460751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
    Dilxat T; Shi Q; Chen X; Liu X
    Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A; Wang S; Zhang J; Wu H
    Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of combination of anakinra and MCC950 against acute lung injury is achieved through suppression of the NF-κB-mediated-MAPK and NLRP3-caspase pathways.
    Wang X; Chen S; Zhao L; Shi X
    Int Immunopharmacol; 2021 Aug; 97():107506. PubMed ID: 34022766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.